JANX - Janux Therapeutics Inc Ordinary Shares (Healthcare: Biotechnology) Projected Earnings Date: 2025-11-05    (Delayed quote data   2025-10-29)
Last
 27.81		 Change
 ⇓ -1.95   (-6.55%)		 Volume
  2,066,953
Open
 29.32		 High
 29.88		 Low
 27.78
8EMA (Daily)
 27.45		 40EMA (Daily)
 25.39		 50EMA (Daily)
 25.23		 STO (Daily)
 67.964		 MACD Hist (Daily)
 0.140
8EMA (Weekly)
 25.829		 40EMA (Weekly)
 28.62		 50EMA (Weekly)
 29.61		 STO (Weekly)
 59.699		 MACD Hist (Weekly)
 0.874
Company Profile
Janux Therapeutics Inc is an innovative biopharmaceutical company developing next-generation therapeutics based on proprietary tumor activated T Cell Engager platform technology to better treat patients suffering from cancer.
optionchance optionchance
⇒ Home | Chart and Research | Education | About Us  

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.

Questions or Comments: support@optionchance.com
Copyright © 2025 OptionChance.com